Shukrit Sudhir Chimote
Chief Executive Officer

Shukrit has a proven track record in the pharmaceutical industry and prior to founding Sayre Therapeutics, he served as Vice-President and India / South-Asia Head, Branded Formulations at Biocon, Bangalore, India. As the strategic business unit head (SBU), his responsibilities spanned the breadth of commercial operations including P&L management. Additionally, he headed global business development for the SBU, and directed strategies across eight business units, driving global in-licensing for them. His earlier roles at the premier Indian biotech included heading the Novel Medicines and Biosimilars’ strategic business units (SBUs).

Prior to this role, Shukrit was employed with Bristol-Myers Squibb, Princeton, New Jersey, US in roles within the Anti-infectives, Cardiology and Immunology franchises. He was also part of the global marketing team where he facilitated the go-to-market strategies for Japan, China, S-E Asia and Indian markets, for a key Immunology first-in-class biological asset.

Shukrit’ s experience set over twenty five years in corporate and academia covers R&D strategy, analytics/market-research, global and in-line marketing and global business development. Shukrit is credited with building robust business lines in India, and drove the commercial strategy for global brands in the US.

Shukrit completed his Bachelor’s degree in Pharmacy from Mumbai, India and his MS in Pharmacology & an MBA in Pharmaceutical marketing from the University of Mississippi, US. He also has a Masters in International affairs from SIPA @ Columbia University, New York. He is married with two kids. Loves sushi and poha, keeps abreast of current political affairs, dreams of being fit and is a voracious TV watcher.